These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Guidelines for antithrombotic therapy in atrial fibrillation: understanding the reasons for non-adherence and moving forwards with simplifying risk stratification for stroke and bleeding. Fauchier L; Lip GY Europace; 2010 Jun; 12(6):761-3. PubMed ID: 20388635 [No Abstract] [Full Text] [Related]
5. Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA2DS2-VASc risk stratification scores. Pamukcu B; Lip GY; Lane DA Age Ageing; 2010 Sep; 39(5):533-5. PubMed ID: 20507847 [No Abstract] [Full Text] [Related]
6. Antithrombotic therapy for stroke prevention in atrial fibrillation. Go AS; Fang MC; Singer DE Prog Cardiovasc Dis; 2005; 48(2):108-24. PubMed ID: 16253651 [TBL] [Abstract][Full Text] [Related]
7. [Atrial fibrillation. What's new in treatment and prophylaxis of embolic complications?]. MusiaĆ WJ Pol Merkur Lekarski; 1996 Nov; 1(5):351-4. PubMed ID: 9273217 [TBL] [Abstract][Full Text] [Related]
8. [What new on the way to the field of stroke prevention?]. Kaste M; Strandberg T; Lindsberg P; Sivenius J Duodecim; 2002; 118(24):2553-61. PubMed ID: 12572291 [No Abstract] [Full Text] [Related]
9. Cerebrovascular and carotid artery disease. August M Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Sep; 92(3):253-6. PubMed ID: 11552139 [No Abstract] [Full Text] [Related]
13. [Primary prevention of stroke. What helps--what does not help? The guidelines of the German Society of Neurology briefly summarized]. Diener HC MMW Fortschr Med; 2003; 145 Suppl 1():9-10. PubMed ID: 12958797 [No Abstract] [Full Text] [Related]
14. Underuse of antithrombotic therapy caused high incidence of ischemic stroke in patients with atrial fibrillation. Yu HC; Tsai YF; Chen MC; Yeh CH Int J Stroke; 2012 Feb; 7(2):112-7. PubMed ID: 22103748 [TBL] [Abstract][Full Text] [Related]
15. Viewpoint: management of atrial fibrillation. Taylor J Circulation; 2006 Aug; 114(7):f126-7. PubMed ID: 16912995 [No Abstract] [Full Text] [Related]
16. The International Stroke Conference 2008, New Orleans, Louisiana, February 20-22, 2008. Skolarus LE; Meurer WJ J Neuroophthalmol; 2008 Sep; 28(3):245-8. PubMed ID: 18769299 [No Abstract] [Full Text] [Related]
17. [Antiplatelet and anticoagulant therapy for stroke prevention in patients with non-valvular atrial fibrillation: evidence based strategies and new developments]. Gersh BJ; Freedman JE; Granger CB Rev Esp Cardiol; 2011 Apr; 64(4):260-8. PubMed ID: 21411211 [No Abstract] [Full Text] [Related]
19. The assessment of stroke and bleeding risk in atrial fibrillation: where are we now? Pamukcu B; Lane DA; Lip GY Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1703-10. PubMed ID: 21108552 [TBL] [Abstract][Full Text] [Related]
20. ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT). Hohnloser SH; Capucci A; Fain E; Gold MR; van Gelder IC; Healey J; Israel CW; Lau CP; Morillo C; Connolly SJ; Am Heart J; 2006 Sep; 152(3):442-7. PubMed ID: 16923410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]